Today, to celebrate the official opening of the new cyclotron, the Thunder Bay Regional Research Institute (TBRRI) and the Thunder Bay Regional Health Sciences Centre (TBRHSC) were joined by funding partners from the Governments of Canada, Ontario and Thunder Bay and the Thunder Bay Regional Health Sciences Foundation.
“This is a game changer,” said Dr. Gary Polonsky, chairman of the TBRRI board. “This gives TBRRI researchers the opportunity to develop and bring cutting-edge healthcare to Thunder Bay, potentially offering new tests to residents of Northwestern Ontario before most other hospitals in Canada or even the world.”
The cyclotron will produce medical isotopes that will improve cancer care for patients in Northwestern Ontario and will allow for cutting-edge research that works to find new, more efficient, ways of diagnosing and treating cancers.
The cyclotron will also ensure more dependable care to local cancer patients using existing therapies, something particularly important to a hospital serving as vast a geographic region as Northwestern Ontario. Previously, isotopes used for patient care were delivered from other sites in Ontario. If there was any delay for any reason, the isotopes decayed to a point where they were no longer useful. Patients’ imaging tests for those days would have to be cancelled and rescheduled.
“Given the short effective life isotopes have, producing them on site eliminates the problem of cancer patients in Northwestern Ontario being at the mercy of unpredictable weather or airline arrivals, which have in the past delayed or cancelled access to potentially life saving treatment,” said TBRHSC Board Chair Susan Fraser.
Removing that uncertainty from patients already dealing with the stress of cancer will improve their experience of care, added Fraser.
Polonsky and Fraser thanked the cyclotron’s funding partners — The Government of Canada’s FedNor program, the Government of Ontario’s Northern Ontario Heritage Fund Corporation, the City of Thunder Bay and the Thunder Bay Regional Health Sciences Foundation’s Exceptional Cancer Care Campaign, for their support of this important initiative.
“Without them, we wouldn’t be standing here today,” said Polonksy. “This is a huge day for the future of cancer care in Northwestern Ontario and possibly Canada and the world,” concluded Polonsky. “Making it to this day has been a true community effort. I thank you and I am confident future generations will thank you.”
Today’s event marks the beginning of a new era for research and innovation in Northwestern Ontario. Establishing a cyclotron in Thunder Bay will further position the region as a global leader for applied research and development in biotechnology, while expanding the health sciences cluster by supporting jobs and growth throughout the area.
– Honourable Greg Rickford, Canada’s Minister of Natural Resources and Minister for the Federal Economic Development Initiative for Northern Ontario
Our government recognizes that the important work conducted at the Thunder Bay Regional Research Institute is emphasizing patient focused health care, providing earlier diagnoses of diseases and better treatment for northerners. I am absolutely delighted that the NOHFC made such a major investment in the Cyclotron project, which is significantly adding to Thunder Bay’s reputation as a world leading centre in health care research.
– Northern Development and Mines Minister Michael Gravelle, who also chairs the Northern Ontario Heritage Fund Corporation
I am pleased that the City of Thunder Bay can count itself among the supporters and funding partners of this innovative medical technology that will transform cancer patient care in our community, and make a significant difference in the lives of our citizens.
– Mayor Keith Hobbs, City of Thunder Bay
It is an honour to represent the thousands of donors who have contributed so generously to the Exceptional Cancer Care Campaign to ensure we have access to equipment, such as the cyclotron, that will provide the very best care possible for cancer patients, both now and in the future.
– Paul Fitzpatrick, Chair, Exceptional Cancer Care Campaign